These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Functional analysis of 22 splice-site mutations in the PHEX, the causative gene in X-linked dominant hypophosphatemic rickets. BinEssa HA; Zou M; Al-Enezi AF; Alomrani B; Al-Faham MSA; Al-Rijjal RA; Meyer BF; Shi Y Bone; 2019 Aug; 125():186-193. PubMed ID: 31102713 [TBL] [Abstract][Full Text] [Related]
26. Incorporation of semi-quantitative analysis of splicing alterations for the clinical interpretation of variants in BRCA1 and BRCA2 genes. Montalban G; Bonache S; Moles-Fernández A; Gadea N; Tenés A; Torres-Esquius S; Carrasco E; Balmaña J; Diez O; Gutiérrez-Enríquez S Hum Mutat; 2019 Dec; 40(12):2296-2317. PubMed ID: 31343793 [TBL] [Abstract][Full Text] [Related]
27. The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer. Neidhardt G; Becker A; Hauke J; Horváth J; Bogdanova Markov N; Heilmann-Heimbach S; Hellebrand H; Thiele H; Altmüller J; Nürnberg P; Meindl A; Rhiem K; Blümcke B; Wappenschmidt B; Schmutzler RK; Hahnen E Eur J Cancer Prev; 2017 Mar; 26(2):165-169. PubMed ID: 27622768 [TBL] [Abstract][Full Text] [Related]
28. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression. Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214 [TBL] [Abstract][Full Text] [Related]
29. Pathogenicity evaluation of variants of uncertain significance at exon-intron junction by splicing assay in patients with Mowat-Wilson syndrome. Suzuki Y; Nomura N; Yamada K; Yamada Y; Fukuda A; Hoshino K; Abe S; Kurosawa K; Inaba M; Mizuno S; Wakamatsu N; Hayashi S Eur J Med Genet; 2023 Dec; 66(12):104882. PubMed ID: 37944854 [TBL] [Abstract][Full Text] [Related]
30. In vitro functional characterization of splicing variants of the APOB gene found in familial hypobetalipoproteinemia. Rabacchi C; Simone ML; Pisciotta L; Di Leo E; Bocchi D; Pietrangelo A; D'Addato S; Bertolini S; Calandra S; Tarugi P J Clin Lipidol; 2019; 13(6):960-969. PubMed ID: 31629702 [TBL] [Abstract][Full Text] [Related]
31. RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families. Krivokuca A; Yanowski K; Rakobradovic J; Benitez J; Brankovic-Magic M Cancer Biomark; 2015; 15(6):775-81. PubMed ID: 26406419 [TBL] [Abstract][Full Text] [Related]
32. Screening BRCA1 and BRCA2 unclassified variants for splicing mutations using reverse transcription PCR on patient RNA and an ex vivo assay based on a splicing reporter minigene. Bonnet C; Krieger S; Vezain M; Rousselin A; Tournier I; Martins A; Berthet P; Chevrier A; Dugast C; Layet V; Rossi A; Lidereau R; Frébourg T; Hardouin A; Tosi M J Med Genet; 2008 Jul; 45(7):438-46. PubMed ID: 18424508 [TBL] [Abstract][Full Text] [Related]
34. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. de la Hoya M; Soukarieh O; López-Perolio I; Vega A; Walker LC; van Ierland Y; Baralle D; Santamariña M; Lattimore V; Wijnen J; Whiley P; Blanco A; Raponi M; Hauke J; Wappenschmidt B; Becker A; Hansen TV; Behar R; Investigators K; Niederacher D; Arnold N; Dworniczak B; Steinemann D; Faust U; Rubinstein W; Hulick PJ; Houdayer C; Caputo SM; Castera L; Pesaran T; Chao E; Brewer C; Southey MC; van Asperen CJ; Singer CF; Sullivan J; Poplawski N; Mai P; Peto J; Johnson N; Burwinkel B; Surowy H; Bojesen SE; Flyger H; Lindblom A; Margolin S; Chang-Claude J; Rudolph A; Radice P; Galastri L; Olson JE; Hallberg E; Giles GG; Milne RL; Andrulis IL; Glendon G; Hall P; Czene K; Blows F; Shah M; Wang Q; Dennis J; Michailidou K; McGuffog L; Bolla MK; Antoniou AC; Easton DF; Couch FJ; Tavtigian S; Vreeswijk MP; Parsons M; Meeks HD; Martins A; Goldgar DE; Spurdle AB Hum Mol Genet; 2016 Jun; 25(11):2256-2268. PubMed ID: 27008870 [TBL] [Abstract][Full Text] [Related]
35. Molecular analysis of eight splicing variants in the hydroxymethylbilane synthase gene. Ren Y; Wang J; Li S; Lei J; Liu Y; Wang Y; Gao F; Wang J; Yin J; Yang J Front Genet; 2023; 14():1291472. PubMed ID: 38075680 [No Abstract] [Full Text] [Related]
36. MLH1 intronic variants mapping to + 5 position of splice donor sites lead to deleterious effects on RNA splicing. Piñero TA; Soukarieh O; Rolain M; Alvarez K; López-Köstner F; Torrezan GT; Carraro DM; De Oliveira Nascimento IL; Bomfim TF; Machado-Lopes TMB; Freitas JC; Toralles MB; Sandes KA; Rossi BM; Junior SA; Meira J; Dominguez-Valentin M; Møller P; Vaccaro CA; Martins A; Pavicic WH Fam Cancer; 2020 Oct; 19(4):323-336. PubMed ID: 32363481 [TBL] [Abstract][Full Text] [Related]
37. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance. Soens ZT; Branch J; Wu S; Yuan Z; Li Y; Li H; Wang K; Xu M; Rajan L; Motta FL; Simões RT; Lopez-Solache I; Ajlan R; Birch DG; Zhao P; Porto FB; Sallum J; Koenekoop RK; Sui R; Chen R Hum Mutat; 2017 Nov; 38(11):1521-1533. PubMed ID: 28714225 [TBL] [Abstract][Full Text] [Related]
38. Usefulness and Limitations of Comprehensive Characterization of mRNA Splicing Profiles in the Definition of the Clinical Relevance of Gelli E; Colombo M; Pinto AM; De Vecchi G; Foglia C; Amitrano S; Morbidoni V; Imperatore V; Manoukian S; Baldassarri M; Lo Rizzo C; Catania L; Frullanti E; Tagliafico E; Cortesi L; Spaggiari F; Mencarelli MA; Trevisson E; Radice P; Renieri A; Ariani F Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30832263 [TBL] [Abstract][Full Text] [Related]
39. Three exonic variants in the COL4A5 gene alter RNA splicing in a minigene assay. Zhang R; Lang Y; Shi X; Zhang Y; Liu X; Pan F; Qiao D; Teng X; Shao L Mol Genet Genomic Med; 2024 Feb; 12(2):e2395. PubMed ID: 38400605 [TBL] [Abstract][Full Text] [Related]
40. Potentially pathogenic germline CHEK2 c.319+2T>A among multiple early-onset cancer families. Dominguez-Valentin M; Nakken S; Tubeuf H; Vodak D; Ekstrøm PO; Nissen AM; Morak M; Holinski-Feder E; Martins A; Møller P; Hovig E Fam Cancer; 2018 Jan; 17(1):141-153. PubMed ID: 28608266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]